MetLife Investment Management’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,540
| Closed | -$428K | – | 3032 |
|
|
2023
Q1 | $428K | Sell |
21,540
-1,284
| -6% | -$22.2K | ﹤0.01% | 1740 |
|
|
2022
Q4 | $311K | Hold |
22,824
| – | – | ﹤0.01% | 1960 |
|
|
2022
Q3 | $316K | Hold |
22,824
| – | – | ﹤0.01% | 1979 |
|
|
2022
Q2 | $328K | Hold |
22,824
| – | – | ﹤0.01% | 1958 |
|
|
2022
Q1 | $516K | Buy |
22,824
+8,987
| +65% | +$174K | ﹤0.01% | 1756 |
|
|
2021
Q4 | $260K | Hold |
13,837
| – | – | ﹤0.01% | 1890 |
|
|
2021
Q3 | $454K | Sell |
13,837
-2,780
| -17% | -$104K | ﹤0.01% | 1568 |
|
|
2021
Q2 | $709K | Hold |
16,617
| – | – | 0.01% | 1366 |
|
|
2021
Q1 | $637K | Hold |
16,617
| – | – | 0.01% | 1387 |
|
|
2020
Q4 | $727K | Hold |
16,617
| – | – | 0.01% | 1276 |
|
|
2020
Q3 | $654K | Buy |
16,617
+1,666
| +11% | +$53.8K | 0.01% | 1234 |
|
|
2020
Q2 | $472K | Hold |
14,951
| – | – | 0.01% | 1414 |
|
|
2020
Q1 | $526K | Hold |
14,951
| – | – | 0.01% | 1191 |
|
|
2019
Q4 | $726K | Hold |
14,951
| – | – | 0.01% | 1256 |
|
|
2019
Q3 | $710K | Hold |
14,951
| – | – | 0.01% | 1233 |
|
|
2019
Q2 | $642K | Hold |
14,951
| – | – | 0.01% | 1339 |
|
|
2019
Q1 | $578K | Hold |
14,951
| – | – | 0.01% | 1367 |
|
|
2018
Q4 | $426K | Hold |
14,951
| – | – | 0.01% | 1466 |
|
|
2018
Q3 | $585K | Hold |
14,951
| – | – | 0.01% | 1435 |
|
|
2018
Q2 | $484K | Hold |
14,951
| – | – | 0.01% | 1422 |
|
|
2018
Q1 | $328K | Hold |
14,951
| – | – | ﹤0.01% | 1630 |
|
|
2017
Q4 | $354K | Buy |
+14,951
| New | +$377K | ﹤0.01% | 1612 |
|
Other funds holding CSII
MetLife Investment Management's CSII Position: Q2 2023 in Review
MetLife Investment Management sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 21,540 shares — an estimated $428K sold.
MetLife Investment Management first reported a position in CSII in Q4 2017 and held it in 22 quarters. The position peaked at $727K in Q4 2020. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- MetLife Investment Management reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- MetLife Investment Management sold 21,540 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $428K.
- MetLife Investment Management first reported a position in Cardiovascular Systems, Inc. in Q4 2017 and held it in 22 quarters.
- MetLife Investment Management's Cardiovascular Systems, Inc. position peaked at $727K in Q4 2020.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.